Category: Regulatory & Safety

Regulatory Insights: Focus on China — New Provisions for Drug Registration in 2020

Regulatory Insights: Flexible Regulatory Pathways Accelerating Access to COVID-19 Treatments

Regulatory Affairs: Mitigating COVID-19’s Impact on Clinical Trials

Regulatory Insights: New and Existing U.S. Expedited Development and Emergency Use Pathways for COVID-19 Programs

Virtual Lab Quality Audits: Are They Here to Stay?

Regulatory Insights: Pandemic Speeds Adoption of Telemedicine in Clinical Trials

Regulatory Insights: COVID-19 and its Impact on the Regulatory Affairs Landscape

Successfully Managing Change in Your Pharmacovigilance System

Successful Partnering in Pharmacovigilance For Clinical Trials